Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

Published:2018-06 Issue:6 Volume:33 Page:1078-1093.e12
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Gogola Ewa,Duarte Alexandra A.,de Ruiter Julian R.,Wiegant Wouter W.,Schmid Jonas A.,de Bruijn Roebi,James Dominic I.,Guerrero Llobet Sergi,Vis Daniel J.,Annunziato Stefano,van den Broek Bram,Barazas Marco,Kersbergen Ariena,van de Ven Marieke,Tarsounas Madalena,Ogilvie Donald J.,van Vugt Marcel,Wessels Lodewyk F.A.,Bartkova Jirina,Gromova Irina,Andújar-Sánchez Miguel,Bartek Jiri,Lopes Massimo,van Attikum Haico,Borst Piet,Jonkers Jos,Rottenberg Sven

Funder

Dutch Cancer Society

Netherlands Organisation for Scientific Research

Netherlands Genomics Initiative

Cancer Research UK

Danish Cancer Society

Swedish Research Council

Cancerfonden

Danish National Research Foundation

Swiss National Science Foundation

Swiss Cancer League

European Research Council

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference76 articles.

1. Radiation-induced mitotic catastrophe in PARG-deficient cells;Amé;J. Cell Sci.,2009

2. Differential expression analysis for sequence count data;Anders;Genome Biol.,2010

3. Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study;Ang;Clin. Cancer Res.,2013

4. Genetic dissection of cancer development, therapy response, and resistance in mouse models of breast cancer;Annunziato;Cold Spring Harb. Symp. Quant. Biol.,2016

5. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial;Audeh;Lancet,2010

Cited by 248 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The fork remodeler helicase-like transcription factor in cancer development: all at once;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes;Expert Review of Anticancer Therapy;2024-09-03

3. PARP1-TRIM44-MRN loop dictates the response to PARP inhibitors;Nucleic Acids Research;2024-09-01

4. PARPi, BRCA, and gaps: controversies and future research;Trends in Cancer;2024-09

5. Strategies for the prevention or reversal of PARP inhibitor resistance;Expert Review of Anticancer Therapy;2024-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3